Back to Search
MOIRA RYNN, M.D.
M.D.
Child & Adolescent Psychiatry Physician
NPI: 1932248705Individual
Specialties, Licenses & Credentials
Child & Adolescent Psychiatry PhysicianPrimary
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
239914(NY)
Research & Publications (20)
Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
PMID 17267793·Am J Psychiatry·2007
5-case
Sertraline in children and adolescents with major depressive disorder.
PMID 17003661·J Am Acad Child Adolesc Psychiatry·2006
2-rct
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
PMID 17311303·Depress Anxiety·2008
4-observational
Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
PMID 18974308·N Engl J Med·2008
4-observational
Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
PMID 17559726·Curr Med Res Opin·2007
8-other
A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.
PMID 17553467·Biol Psychiatry·2007
2-rct
Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment.
PMID 17705562·Paediatr Drugs·2007
6-review
Treatment preferences affect the therapeutic alliance: implications for randomized controlled trials.
PMID 17295580·J Consult Clin Psychol·2007
2-rct
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.
PMID 17017821·J Clin Psychiatry·2006
4-observational
Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.
PMID 16848646·J Clin Psychiatry·2006
4-observational
Early response and 8-week treatment outcome in GAD.
PMID 16845651·Depress Anxiety·2006
4-observational
The psychometric properties of the MASC in a pediatric psychiatric sample.
PMID 16464701·J Anxiety Disord·2006
4-observational
Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
PMID 16426087·J Clin Psychiatry·2006
4-observational
Explanatory style change in supportive-expressive dynamic therapy.
PMID 15625679·J Clin Psychol·2005
8-other
Cognitive behavioral and attachment based family therapy for anxious adolescents: Phase I and II studies.
PMID 15721570·J Anxiety Disord·2005
3-trial
Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.
PMID 16160630·J Clin Psychopharmacol·2005
3-trial
Paroxetine in the treatment of generalised anxiety disorder.
PMID 15264994·Expert Opin Pharmacother·2004
6-review
49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry. 22-27 October 2002, San Francisco, CA, USA.
PMID 12667122·Expert Opin Pharmacother·2003
8-other
Ziprasidone-associated mania: a case series and review of the mechanism.
PMID 12656943·Bipolar Disord·2003
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1051 RIVERSIDE DR, UNIT 74
NEW YORK, NY 10032 - Phone
- (212) 543-4506
Quick Facts
- NPI
- 1932248705
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile